These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35436670)

  • 1. Design, synthesis and preclinical evaluation of bio-conjugated amylinomimetic peptides as long-acting amylin receptor agonists.
    Patch RJ; Zhang R; Edavettal S; Macielag MJ; Eckardt AJ; Li J; Rives ML; Edwards W; Hinke SA; Qiu X; Jian W; Libiger O; Zheng S; Jeyaseelan J; Liang Y; Rangwala SM; Leonard JN; Hornby P
    Eur J Med Chem; 2022 Jun; 236():114330. PubMed ID: 35436670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of pramlintide on satiety and food intake in obese subjects and subjects with type 2 diabetes.
    Chapman I; Parker B; Doran S; Feinle-Bisset C; Wishart J; Strobel S; Wang Y; Burns C; Lush C; Weyer C; Horowitz M
    Diabetologia; 2005 May; 48(5):838-48. PubMed ID: 15843914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amylin and Calcitonin: Potential Therapeutic Strategies to Reduce Body Weight and Liver Fat.
    Mathiesen DS; Lund A; Vilsbøll T; Knop FK; Bagger JI
    Front Endocrinol (Lausanne); 2020; 11():617400. PubMed ID: 33488526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pramlintide: (AC 137, AC 0137, Symlin, Tripro-Amylin).
    BioDrugs; 2003; 17(1):73-9. PubMed ID: 12534323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Convergent chemoenzymatic synthesis of a library of glycosylated analogues of pramlintide: structure-activity relationships for amylin receptor agonism.
    Kowalczyk R; Brimble MA; Tomabechi Y; Fairbanks AJ; Fletcher M; Hay DL
    Org Biomol Chem; 2014 Nov; 12(41):8142-51. PubMed ID: 25030939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucoregulatory effects and prolonged duration of action of davalintide: a novel amylinomimetic peptide.
    Mack CM; Smith PA; Athanacio JR; Xu K; Wilson JK; Reynolds JM; Jodka CM; Lu MG; Parkes DG
    Diabetes Obes Metab; 2011 Dec; 13(12):1105-13. PubMed ID: 21733060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does receptor balance matter? - Comparing the efficacies of the dual amylin and calcitonin receptor agonists cagrilintide and KBP-336 on metabolic parameters in preclinical models.
    Larsen AT; Mohamed KE; Sonne N; Bredtoft E; Andersen F; Karsdal MA; Henriksen K
    Biomed Pharmacother; 2022 Dec; 156():113842. PubMed ID: 36242844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloidogenesis of the amylin analogue pramlintide.
    da Silva DC; Fontes GN; Erthal LC; Lima LM
    Biophys Chem; 2016 Dec; 219():1-8. PubMed ID: 27665170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pramlintide treatment reduces 24-h caloric intake and meal sizes and improves control of eating in obese subjects: a 6-wk translational research study.
    Smith SR; Blundell JE; Burns C; Ellero C; Schroeder BE; Kesty NC; Chen KS; Halseth AE; Lush CW; Weyer C
    Am J Physiol Endocrinol Metab; 2007 Aug; 293(2):E620-7. PubMed ID: 17505051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of 14 days' subcutaneous administration of the human amylin analogue, pramlintide (AC137), on an intravenous insulin challenge and response to a standard liquid meal in patients with IDDM.
    Kolterman OG; Schwartz S; Corder C; Levy B; Klaff L; Peterson J; Gottlieb A
    Diabetologia; 1996 Apr; 39(4):492-9. PubMed ID: 8778001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Cagrilintide, a Long-Acting Amylin Analogue.
    Kruse T; Hansen JL; Dahl K; Schäffer L; Sensfuss U; Poulsen C; Schlein M; Hansen AMK; Jeppesen CB; Dornonville de la Cour C; Clausen TR; Johansson E; Fulle S; Skyggebjerg RB; Raun K
    J Med Chem; 2021 Aug; 64(15):11183-11194. PubMed ID: 34288673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical studies.
    Young A
    Adv Pharmacol; 2005; 52():289-320. PubMed ID: 16492555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pramlintide acetate.
    McQueen J
    Am J Health Syst Pharm; 2005 Nov; 62(22):2363-72. PubMed ID: 16278328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central control of energy balance by amylin and calcitonin receptor agonists and their potential for treatment of metabolic diseases.
    Zakariassen HL; John LM; Lutz TA
    Basic Clin Pharmacol Toxicol; 2020 Sep; 127(3):163-177. PubMed ID: 32363722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective Effects of the Amylin Analog, Pramlintide, on Alzheimer's Disease Are Associated with Oxidative Stress Regulation Mechanisms.
    Patrick S; Corrigan R; Grizzanti J; Mey M; Blair J; Pallas M; Camins A; Lee HG; Casadesus G
    J Alzheimers Dis; 2019; 69(1):157-168. PubMed ID: 30958347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective effects of the amylin analogue pramlintide on Alzheimer's disease pathogenesis and cognition.
    Adler BL; Yarchoan M; Hwang HM; Louneva N; Blair JA; Palm R; Smith MA; Lee HG; Arnold SE; Casadesus G
    Neurobiol Aging; 2014 Apr; 35(4):793-801. PubMed ID: 24239383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects on plasma glucose and lactate.
    Young A
    Adv Pharmacol; 2005; 52():193-208. PubMed ID: 16492547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [D-Leu-4]-OB3, a synthetic peptide amide with leptin-like activity, augments the effects of orally delivered exenatide and pramlintide acetate on energy balance and glycemic control in insulin-resistant male C57BLK/6-m db/db mice.
    Leinung MC; Grasso P
    Regul Pept; 2012 Nov; 179(1-3):33-8. PubMed ID: 22960403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infusion of pramlintide, a human amylin analogue, delays gastric emptying in men with IDDM.
    Kong MF; King P; Macdonald IA; Stubbs TA; Perkins AC; Blackshaw PE; Moyses C; Tattersall RB
    Diabetologia; 1997 Jan; 40(1):82-8. PubMed ID: 9028722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of pramlintide on energy intake and food preference in rats given a choice diet.
    Kern KA; DiBrog AM; Przybysz JT; Mietlicki-Baase EG
    Physiol Behav; 2021 Oct; 240():113541. PubMed ID: 34332974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.